1233 related articles for article (PubMed ID: 26916734)
1. Basigin Promotes Cardiac Fibrosis and Failure in Response to Chronic Pressure Overload in Mice.
Suzuki K; Satoh K; Ikeda S; Sunamura S; Otsuki T; Satoh T; Kikuchi N; Omura J; Kurosawa R; Nogi M; Numano K; Sugimura K; Aoki T; Tatebe S; Miyata S; Mukherjee R; Spinale FG; Kadomatsu K; Shimokawa H
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):636-46. PubMed ID: 26916734
[TBL] [Abstract][Full Text] [Related]
2. Lansoprazole alleviates pressure overload-induced cardiac hypertrophy and heart failure in mice by blocking the activation of β-catenin.
Lin H; Li Y; Zhu H; Wang Q; Chen Z; Chen L; Zhu Y; Zheng C; Wang Y; Liao W; Bin J; Kitakaze M; Liao Y
Cardiovasc Res; 2020 Jan; 116(1):101-113. PubMed ID: 30689763
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor-2 mediates adaptive cardiac hypertrophy in response to pressure overload through interleukin-1β upregulation via nuclear factor κB activation.
Higashikuni Y; Tanaka K; Kato M; Nureki O; Hirata Y; Nagai R; Komuro I; Sata M
J Am Heart Assoc; 2013 Nov; 2(6):e000267. PubMed ID: 24249711
[TBL] [Abstract][Full Text] [Related]
4. Ablation of mineralocorticoid receptors in myocytes but not in fibroblasts preserves cardiac function.
Lother A; Berger S; Gilsbach R; Rösner S; Ecke A; Barreto F; Bauersachs J; Schütz G; Hein L
Hypertension; 2011 Apr; 57(4):746-54. PubMed ID: 21321305
[TBL] [Abstract][Full Text] [Related]
5. Ecto-5'-nucleotidase deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction.
Xu X; Fassett J; Hu X; Zhu G; Lu Z; Li Y; Schnermann J; Bache RJ; Chen Y
Hypertension; 2008 Jun; 51(6):1557-64. PubMed ID: 18391093
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin RNA aptamer can prevent and reverse pressure overload-induced heart failure.
Li J; Yousefi K; Ding W; Singh J; Shehadeh LA
Cardiovasc Res; 2017 May; 113(6):633-643. PubMed ID: 28453726
[TBL] [Abstract][Full Text] [Related]
7. Protective Roles of Interferon-γ in Cardiac Hypertrophy Induced by Sustained Pressure Overload.
Kimura A; Ishida Y; Furuta M; Nosaka M; Kuninaka Y; Taruya A; Mukaida N; Kondo T
J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29555642
[TBL] [Abstract][Full Text] [Related]
8. Disruption of actin dynamics regulated by Rho effector mDia1 attenuates pressure overload-induced cardiac hypertrophic responses and exacerbates dysfunction.
Abe I; Terabayashi T; Hanada K; Kondo H; Teshima Y; Ishii Y; Miyoshi M; Kira S; Saito S; Tsuchimochi H; Shirai M; Yufu K; Arakane M; Daa T; Thumkeo D; Narumiya S; Takahashi N; Ishizaki T
Cardiovasc Res; 2021 Mar; 117(4):1103-1117. PubMed ID: 32647865
[TBL] [Abstract][Full Text] [Related]
9. In vivo cardiac role of migfilin during experimental pressure overload.
Haubner BJ; Moik D; Schuetz T; Reiner MF; Voelkl JG; Streil K; Bader K; Zhao L; Scheu C; Mair J; Pachinger O; Metzler B
Cardiovasc Res; 2015 Jun; 106(3):398-407. PubMed ID: 25852081
[TBL] [Abstract][Full Text] [Related]
10. Pressure-mediated hypertrophy and mechanical stretch induces IL-1 release and subsequent IGF-1 generation to maintain compensative hypertrophy by affecting Akt and JNK pathways.
Honsho S; Nishikawa S; Amano K; Zen K; Adachi Y; Kishita E; Matsui A; Katsume A; Yamaguchi S; Nishikawa K; Isoda K; Riches DW; Matoba S; Okigaki M; Matsubara H
Circ Res; 2009 Nov; 105(11):1149-58. PubMed ID: 19834007
[TBL] [Abstract][Full Text] [Related]
11. Activation of the Amino Acid Response Pathway Blunts the Effects of Cardiac Stress.
Qin P; Arabacilar P; Bernard RE; Bao W; Olzinski AR; Guo Y; Lal H; Eisennagel SH; Platchek MC; Xie W; Del Rosario J; Nayal M; Lu Q; Roethke T; Schnackenberg CG; Wright F; Quaile MP; Halsey WS; Hughes AM; Sathe GM; Livi GP; Kirkpatrick RB; Qu XA; Rajpal DK; Faelth Savitski M; Bantscheff M; Joberty G; Bergamini G; Force TL; Gatto GJ; Hu E; Willette RN
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28487390
[TBL] [Abstract][Full Text] [Related]
12. Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stress.
Oudit GY; Kassiri Z; Zhou J; Liu QC; Liu PP; Backx PH; Dawood F; Crackower MA; Scholey JW; Penninger JM
Cardiovasc Res; 2008 Jun; 78(3):505-14. PubMed ID: 18281373
[TBL] [Abstract][Full Text] [Related]
13. Basigin mediates pulmonary hypertension by promoting inflammation and vascular smooth muscle cell proliferation.
Satoh K; Satoh T; Kikuchi N; Omura J; Kurosawa R; Suzuki K; Sugimura K; Aoki T; Nochioka K; Tatebe S; Miyamichi-Yamamoto S; Miura M; Shimizu T; Ikeda S; Yaoita N; Fukumoto Y; Minami T; Miyata S; Nakamura K; Ito H; Kadomatsu K; Shimokawa H
Circ Res; 2014 Sep; 115(8):738-50. PubMed ID: 25149188
[TBL] [Abstract][Full Text] [Related]
14. BMP-7 attenuates left ventricular remodelling under pressure overload and facilitates reverse remodelling and functional recovery.
Merino D; Villar AV; García R; Tramullas M; Ruiz L; Ribas C; Cabezudo S; Nistal JF; Hurlé MA
Cardiovasc Res; 2016 Jun; 110(3):331-45. PubMed ID: 27068510
[TBL] [Abstract][Full Text] [Related]
15. Long pentraxin PTX3 exacerbates pressure overload-induced left ventricular dysfunction.
Suzuki S; Shishido T; Funayama A; Netsu S; Ishino M; Kitahara T; Sasaki T; Katoh S; Otaki Y; Watanabe T; Shibata Y; Mantovani A; Takeishi Y; Kubota I
PLoS One; 2013; 8(1):e53133. PubMed ID: 23372656
[TBL] [Abstract][Full Text] [Related]
16. Intercellular Adhesion Molecule 1 Regulates Left Ventricular Leukocyte Infiltration, Cardiac Remodeling, and Function in Pressure Overload-Induced Heart Failure.
Salvador AM; Nevers T; Velázquez F; Aronovitz M; Wang B; Abadía Molina A; Jaffe IZ; Karas RH; Blanton RM; Alcaide P
J Am Heart Assoc; 2016 Mar; 5(3):e003126. PubMed ID: 27068635
[TBL] [Abstract][Full Text] [Related]
17. Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload-induced heart failure.
Szabó Z; Magga J; Alakoski T; Ulvila J; Piuhola J; Vainio L; Kivirikko KI; Vuolteenaho O; Ruskoaho H; Lipson KE; Signore P; Kerkelä R
Hypertension; 2014 Jun; 63(6):1235-40. PubMed ID: 24688123
[TBL] [Abstract][Full Text] [Related]
18. Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress.
Kandalam V; Basu R; Moore L; Fan D; Wang X; Jaworski DM; Oudit GY; Kassiri Z
Circulation; 2011 Nov; 124(19):2094-105. PubMed ID: 21986284
[TBL] [Abstract][Full Text] [Related]
19. The ATP-binding cassette transporter ABCG2 protects against pressure overload-induced cardiac hypertrophy and heart failure by promoting angiogenesis and antioxidant response.
Higashikuni Y; Sainz J; Nakamura K; Takaoka M; Enomoto S; Iwata H; Tanaka K; Sahara M; Hirata Y; Nagai R; Sata M
Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):654-61. PubMed ID: 22116099
[TBL] [Abstract][Full Text] [Related]
20. Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice.
Wang AW; Song L; Miao J; Wang HX; Tian C; Jiang X; Han QY; Yu L; Liu Y; Du J; Xia YL; Li HH
Am J Hypertens; 2015 Apr; 28(4):518-26. PubMed ID: 25362112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]